Woman who had $400-a-day nitrous oxide habit is found dead outside smoke shop
Meg Caldwell, 29, of Clermont in the Orlando area, was found dead outside a smoke shop in late 2024 years after becoming hooked on whippets, a slang term for canisters that contain nitrous oxide.
She began doing whippets recreationally in college before it spiraled into a full–fledged addiction, her sister said.
Leigh Caldwell told Boston 25: 'She would spend $300, $400 at a smoke shop in a day.'
On one occasion, after overdosing on the drug, Meg temporarily lost use of her legs.
Leigh said: 'A doctor in the hospital said, "This is going to kill you. You're going to die."'
Even after the terrifying experience, she continued to use nitrous oxide.
Leigh added:'Her whole life had become derailed due to her addiction to this drug.'
Meg would buy nitrous oxide from local smoke shops, inhale it in the parking lot and then head back inside for more.
Another sister, Kathleen Dial, told the BBC: 'She didn't think that it would hurt her because she was buying it in the smoke shop, so she thought she was using this substance legally.'
The youngest of four sisters, Meg was 'the light of our lives,' Dial added.
Nitrous oxide - also known as laughing gas - is sold legally in the US, though some states regulate the product's sale.
Meg's family has filed a class action lawsuit against the manufacturers of nitrous oxide and seven Florida smoke shops to stop retail sales of the drug.
John Allen Yanchunis, an attorney who represents the Caldwells, said: 'This is not a wrongful death case. The Caldwells made a decision that their focus would be for the public good.'
Meg isn't the only one who has suffered from the dangerous addiction.
From 2019 to 2023, the number of deaths attributed to nitrous oxide poisoning rose by more than 100 percent, according to the CDC.
Dr Gaylord Lopez, executive director of the Georgia Poison Centertold Boston 25 that 'a lot of these patients are adults who are being seen in the emergency room after having experienced blackouts, unconsciousness.'
He described how chronic use of nitrous oxide robs the brain and heart of oxygen. This can lead to blood conditions, blood clots and temporary paralysis.
Nitrous oxide can cause death through a lack of oxygen, or by the substance's effect on the cardiovascular system – as it can lead to dangerous changes in heart rate and blood pressure.
Drug addiction counselor Kim Castro told Boston 25 that she's had four clients who have died from nitrous oxide poisoning.
She said: 'You really don't know when you'll stop breathing, when you'll lose consciousness, when your body will stop functioning. It's pretty scary.'
Galaxy Gas, a company that produces flavored whipped-cream chargers and dispensers containing nitrous oxide, is named in the lawsuit.
Its dispensers became famous after going viral last year, as people filmed themselves using the products. TikTok has since blocked 'Galaxy Gas' as a search result.
In March, the FDA released a statement advising consumers not to inhale nitrous oxide products, including Galaxy Gas and many other brands.
Lawyers for the brand said it was sold to a Chinese company last year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
20 minutes ago
- The Independent
Brooke Hogan has questions about her dad's death
WWE legend Hulk Hogan passed away on 24 July at the age of 71, with his funeral held privately in Florida. Medical records obtained by The Independent indicate his cause of death was a heart attack, alongside a previously unknown diagnosis of chronic lymphocytic leukaemia. Hogan's estranged daughter, Brooke Hogan Oleksy, has publicly questioned the circumstances surrounding his death. Brooke shared a news article on Instagram highlighting concerns about a 'quick cremation without autopsy' and further discussed these doubts on a radio show. She specifically raised questions about the undiagnosed leukaemia and the absence of an autopsy, despite medical records confirming acute myocardial infarction and chronic lymphocytic leukaemia.
The Independent
20 minutes ago
- The Independent
Trump calls RFK Jr ‘three or four times a week' with the same question
Health and Human Services Secretary Robert F. Kennedy Jr said that President Donald Trump calls him up 'three or four times a week' to hound him with the same question. Kennedy was speaking at an event Monday with Secretary of Agriculture Brooke Rollins to push a policy banning sugary drinks, candy and junk food from the Supplemental Nutrition Assistance Program, as part of his 'Make America Healthy Again' agenda. Six months into his second term, Trump wants to know 'why aren't people healthier yet,' Kennedy told reporters at the press conference. 'We have full support from the president,' Kennedy said. 'He wants this done. He promised to make America healthy again, and he's gonna do that.' 'He called me last night,' Kennedy added, referring to the president. 'He calls me three or four times a week and says, 'Where are you? Why aren't people healthier yet?' So he's keeping me under pressure.' Monday's event was promoting a policy adopted by West Virginia, Texas, Colorado, Louisiana, Oklahoma and Florida, barring SNAP participants from using food stamps to buy junk food. They join Arkansas, Idaho, Utah, Iowa, Indiana and Nebraska in the SNAP waiver initiative. SNAP is a lifeline that keeps more than 41 million Americans, or 12 percent of the population, from going hungry. More than 13 million recipients are children. Over the past 20 years, lawmakers in several states have proposed stopping SNAP from paying for everything from bottled water and soda to chips, ice cream and 'luxury meats' such as steak. Critics said that the SNAP waiver 'ignores decades of evidence showing that incentive-based approaches — not punitive restrictions — are the most effective, dignified path to improving nutrition and reducing hunger,' said Gina Plata-Nino, a deputy director at the Food Research & Action Center, a nonprofit advocacy group. Trump passed the largest-ever cuts to the program in his signature 'One Big, Beautiful Bill' by restricting eligibility for SNAP enrollment and diverting a significant chunk of the program's costs to states.
The Independent
20 minutes ago
- The Independent
‘We will work collaboratively': Big Pharma admits it is discussing Trump's plan to lower drug prices
Pfizer CEO Albert Bourla says that his company and other large pharmaceutical firms are looking at working with the Trump administration to make more of their medicines available at lower costs to consumers. In a conference call with investors on Tuesday to discuss second-quarter earnings, Bourla said, 'We have serious discussions in the industry,' according to BioPharma Dive. 'I'm connected very often individually with all the major companies, and they are all ready to roll up their sleeves and execute something like that,' he added. Bourla leads Pfizer and is the board chair of PhRMA, the industry lobbying group. Pfizer and its partner Bristol Myers Squibb recently revealed plans to make their blood thinner Eliquis available at a lower price online. The firm previously started a direct-to-consumer service that lets patients book telehealth appointments, schedule vaccinations, and fill some prescriptions. 'We think it is a fantastic way to go ahead, so we will work collaboratively to do it,' said Bourla. Eli Lilly and Novo Nordisk, both makers of obesity drugs, have also put forward more ways that patients who pay in cash can access the weight-loss drugs directly. Other companies are also showing interest in the effort, looking at ways to make drugs available without pharmacy benefit managers — the middlemen getting rebates from drugmakers that insurers claim lower the overall cost, but not in ways that are clear to a patient filling a prescription. In letters to 17 drugmakers last week, Trump demanded that direct-to-consumer options be expanded. He said he would use 'every tool' available to him if the companies don't act to lower the cost of their products to prices seen in other industrialized countries. Trump has indicated that the policy would be limited to Medicaid, and analysts aren't unified on how much of an impact it would have. During the call on Tuesday, Bourla noted that he's in 'active discussions' with the 'highest levels of the U.S. government,' according to BioPharma Dive. That includes speaking to Trump, Health and Human Services Secretary Robert F. Kennedy Jr., and the Administrator of the Centers for Medicare and Medicaid Services, Mehmet Oz. 'The letter asks a lot from us,' said Bourla. 'But we are engaged in productive discussion with them and in general, I'm happy with the way that they listen to us.' Amid an investigation into pharmaceutical imports, the Commerce Department is expected to impose sector-specific tariffs. Trump told CNBC on Tuesday that his administration would at first put in place smaller tariffs on pharmaceuticals, which could subsequently rise to as much as 250 percent. While the tariffs would be expensive for drugmakers, analysts think that a phase-in period would mean that many companies could change their supply chains to avoid the worst of the financial repercussions, BioPharma Dive noted. Most of the biggest drugmakers have already revealed significant investment in manufacturing in the U.S. Pfizer indicated that it would be able to take on the tariffs this year, including any possible changes to its pricing, and still meet its financial forecast of revenues measuring between $61 billion and $64 billion. Trump has made impossible promises on drug prices, saying he's cut them by up to 1,500 percent. 'You know, we've cut drug prices by 1,200, 1,300, 1,400, 1,500 percent. I don't mean 50 percent, I mean 14 — 1,500 percent,' Trump told reporters on Sunday. This is inaccurate, as cutting prices by more than 100 percent would mean that consumers are being paid to take the drugs. The director of health policy at the University of Southern California's Schaeffer Center, Geoffrey Joyce, called the claim 'total fiction.' Mariana Socal is an associate professor of health policy and management at Johns Hopkins University. 'I find it really difficult to translate those numbers into some actual estimates that patients would see at the pharmacy counter,' she said. 'It's an objective fact that Americans are paying exponentially more for the same exact drugs as people in other developed countries pay, and it's an objective fact that no other Administration has done more to rectify this unfair burden for the American people,' a White House spokesperson said.
